Osaic Holdings’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5K Sell
757
-50
-6% -$2.05K ﹤0.01% 5549
2025
Q4
$31.1K Buy
807
+504
+166% +$17.1K ﹤0.01% 5565
2025
Q3
$8.27K Hold
303
﹤0.01% 6478
2025
Q2
$5.86K Buy
+303
New +$5.5K ﹤0.01% 6455
2025
Q1
Sell
-447
Closed -$10.7K 7455
2024
Q4
$10.7K Hold
447
﹤0.01% 5761
2024
Q3
$12.5K Hold
447
﹤0.01% 5677
2024
Q2
$11.3K Hold
447
﹤0.01% 5702
2024
Q1
$13K Hold
447
﹤0.01% 5607
2023
Q4
$10.9K Hold
447
﹤0.01% 5790
2023
Q3
$8.77K Sell
447
-300
-40% -$6.66K ﹤0.01% 5995
2023
Q2
$17.9K Buy
747
+73
+11% +$1.76K ﹤0.01% 5644
2023
Q1
$14.8K Hold
674
﹤0.01% 5752
2022
Q4
$17K Sell
674
-9,660
-93% -$240K ﹤0.01% 5669
2022
Q3
$253K Buy
10,334
+985
+11% +$25.1K ﹤0.01% 3530
2022
Q2
$202K Buy
9,349
+6,800
+267% +$149K ﹤0.01% 3784
2022
Q1
$72K Sell
2,549
-56
-2% -$1.66K ﹤0.01% 4819
2021
Q4
$101K Sell
2,605
-300
-10% -$12.8K ﹤0.01% 4587
2021
Q3
$133K Buy
2,905
+70
+2% +$3.27K ﹤0.01% 4275
2021
Q2
$141K Sell
2,835
-1,568
-36% -$76.7K ﹤0.01% 4188
2021
Q1
$226K Sell
4,403
-175
-4% -$9.57K ﹤0.01% 3623
2020
Q4
$227K Sell
4,578
-10,315
-69% -$463K ﹤0.01% 3364
2020
Q3
$580K Sell
14,893
-447
-3% -$18.2K ﹤0.01% 2303
2020
Q2
$663K Buy
15,340
+6,719
+78% +$257K ﹤0.01% 2099
2020
Q1
$253K Buy
+8,621
New +$297K ﹤0.01% 2685

Other funds holding BBC

Osaic Holdings's BBC Position: Q1 2026 in Review

Osaic Holdings reduced its Virtus Biotech Clinical Trials ETF (BBC) stake by 6.2% in Q1 2026, selling an estimated $2.05K and leaving 757 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5549.

Osaic Holdings first reported a position in BBC in Q1 2020 and has held it in 24 quarters since. The position peaked at $663K in Q2 2020. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

  • Osaic Holdings held 757 shares of Virtus Biotech Clinical Trials ETF worth $31.5K as of Q1 2026.
  • Osaic Holdings sold 50 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $2.05K.
  • Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5549 holding.
  • Osaic Holdings first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Virtus Biotech Clinical Trials ETF position peaked at $663K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.